IL231403A0 - Thiazolopyridine compounds as a10pde inhibitors - Google Patents

Thiazolopyridine compounds as a10pde inhibitors

Info

Publication number
IL231403A0
IL231403A0 IL231403A IL23140314A IL231403A0 IL 231403 A0 IL231403 A0 IL 231403A0 IL 231403 A IL231403 A IL 231403A IL 23140314 A IL23140314 A IL 23140314A IL 231403 A0 IL231403 A0 IL 231403A0
Authority
IL
Israel
Prior art keywords
pde10a inhibitors
triazolopyridine compounds
triazolopyridine
compounds
pde10a
Prior art date
Application number
IL231403A
Other languages
English (en)
Hebrew (he)
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=46851999&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL231403(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of IL231403A0 publication Critical patent/IL231403A0/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Psychology (AREA)
  • Emergency Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Oncology (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Addiction (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
IL231403A 2011-09-19 2014-03-06 Thiazolopyridine compounds as a10pde inhibitors IL231403A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP11181752 2011-09-19
PCT/EP2012/068203 WO2013041472A1 (en) 2011-09-19 2012-09-17 Triazolopyridine compounds as pde10a inhibitors

Publications (1)

Publication Number Publication Date
IL231403A0 true IL231403A0 (en) 2014-04-30

Family

ID=46851999

Family Applications (1)

Application Number Title Priority Date Filing Date
IL231403A IL231403A0 (en) 2011-09-19 2014-03-06 Thiazolopyridine compounds as a10pde inhibitors

Country Status (19)

Country Link
US (2) US8946427B2 (cg-RX-API-DMAC7.html)
EP (1) EP2758396B1 (cg-RX-API-DMAC7.html)
JP (1) JP2014526533A (cg-RX-API-DMAC7.html)
KR (1) KR101584925B1 (cg-RX-API-DMAC7.html)
CN (1) CN103827114B (cg-RX-API-DMAC7.html)
AU (1) AU2012311713A1 (cg-RX-API-DMAC7.html)
BR (1) BR112014006248A2 (cg-RX-API-DMAC7.html)
CA (1) CA2846758C (cg-RX-API-DMAC7.html)
CL (1) CL2014000641A1 (cg-RX-API-DMAC7.html)
CO (1) CO6900144A2 (cg-RX-API-DMAC7.html)
EA (1) EA201490599A1 (cg-RX-API-DMAC7.html)
ES (1) ES2626801T3 (cg-RX-API-DMAC7.html)
IL (1) IL231403A0 (cg-RX-API-DMAC7.html)
MX (1) MX2014003025A (cg-RX-API-DMAC7.html)
PE (1) PE20141553A1 (cg-RX-API-DMAC7.html)
PH (1) PH12014500499A1 (cg-RX-API-DMAC7.html)
SG (1) SG11201400759RA (cg-RX-API-DMAC7.html)
UA (1) UA108711C2 (cg-RX-API-DMAC7.html)
WO (1) WO2013041472A1 (cg-RX-API-DMAC7.html)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013043518A1 (en) 2011-09-22 2013-03-28 Merck Sharp & Dohme Corp. Imidazopyridyl compounds as aldosterone synthase inhibitors
US9193724B2 (en) 2011-09-22 2015-11-24 Merck Sharp & Dohme Corp. Triazolopyridyl compounds as aldosterone synthase inhibitors
AR096118A1 (es) * 2013-04-30 2015-12-09 Hoffmann La Roche Condensación de pirazol-amidas catalizadas con pd
TWI652014B (zh) 2013-09-13 2019-03-01 美商艾佛艾姆希公司 雜環取代之雙環唑殺蟲劑
US9879009B2 (en) 2014-07-30 2018-01-30 Mochida Pharmaceutical Co., Ltd. Pyrazole derivative manufacturing method
CN107074844A (zh) * 2014-07-30 2017-08-18 持田制药株式会社 吡唑衍生物的制造方法
WO2016144351A1 (en) 2015-03-11 2016-09-15 E. I. Du Pont De Nemours And Company Heterocycle-substituted bicyclic azole pesticides
EP3268359B1 (en) 2015-03-12 2019-12-18 FMC Corporation Heterocycle-substituted bicyclic azole pesticides
US10800794B2 (en) 2015-10-08 2020-10-13 Fmc Corporation Heterocycle-substituted bicyclic azole pesticides
KR102600330B1 (ko) 2017-08-22 2023-11-10 바이엘 악티엔게젤샤프트 해충 방제제로서의 헤테로시클렌 유도체
ES2969738T3 (es) 2019-05-27 2024-05-22 Nihon Nohyaku Co Ltd Compuesto heterocíclico condensado que tiene un átomo de nitrógeno como cabeza de puente o una sal del mismo, insecticida agrícola u hortícola que comprende el compuesto y método para usar el insecticida
AR119140A1 (es) 2019-06-13 2021-11-24 Pi Industries Ltd Compuestos heterocíclicos fusionados y su uso como agentes de control de plagas
CN110396157B (zh) * 2019-08-07 2021-07-30 广州市建筑科学研究院有限公司 缓释型聚羧酸纳米减水剂及其制备方法和应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6355653B1 (en) * 1999-09-06 2002-03-12 Hoffmann-La Roche Inc. Amino-triazolopyridine derivatives
JP2007508241A (ja) 2003-07-31 2007-04-05 バイエル・フアーマシユーチカルズ・コーポレーシヨン Ｐｄｅ１０ａ阻害剤を用いる糖尿病および関連障害の処置方法
NL2000397C2 (nl) * 2006-01-05 2007-10-30 Pfizer Prod Inc Bicyclische heteroarylverbindingen als PDE10 inhibitoren.
JPWO2010035745A1 (ja) * 2008-09-25 2012-02-23 杏林製薬株式会社 ヘテロ環ビアリール誘導体及びそれらを有効成分とするｐｄｅ阻害剤
WO2010059836A1 (en) * 2008-11-20 2010-05-27 Decode Genetics Ehf Substituted aza-bridged bicyclics for cardiovascular and cns disease
WO2010117926A1 (en) * 2009-04-07 2010-10-14 Schering Corporation Substituted triazolopyridines and analogs thereof
KR101426624B1 (ko) * 2009-09-24 2014-08-05 에프. 호프만-라 로슈 아게 포스포다이에스터라제 10a 억제제로서 이미다조피리딘 또는 이미다조피리미딘 유도체
CN102696239B (zh) 2009-11-24 2020-08-25 诺基亚技术有限公司 一种设备
TWI485151B (zh) * 2009-12-17 2015-05-21 Lundbeck & Co As H 作為ｐｄｅ１０ａ酵素抑制劑之雜芳香族苯基咪唑衍生物
TW201200516A (en) * 2009-12-17 2012-01-01 Lundbeck & Co As H Phenylimidazole derivatives comprising an ethynylene linker as PDE10A enzyme inhibitors
TWI487705B (zh) * 2009-12-17 2015-06-11 Lundbeck & Co As H 作為ｐｄｅ１０ａ酵素抑制劑之雜芳香族芳基三唑衍生物

Also Published As

Publication number Publication date
UA108711C2 (uk) 2015-05-25
EP2758396B1 (en) 2017-03-29
US20140303141A1 (en) 2014-10-09
BR112014006248A2 (pt) 2017-04-11
AU2012311713A1 (en) 2014-03-13
US20150099735A1 (en) 2015-04-09
PE20141553A1 (es) 2014-10-30
MX2014003025A (es) 2014-05-28
US9227970B2 (en) 2016-01-05
CL2014000641A1 (es) 2014-11-14
NZ621597A (en) 2015-04-24
JP2014526533A (ja) 2014-10-06
CN103827114A (zh) 2014-05-28
WO2013041472A1 (en) 2013-03-28
EA201490599A1 (ru) 2014-07-30
CA2846758A1 (en) 2013-03-28
ES2626801T3 (es) 2017-07-26
CN103827114B (zh) 2016-08-24
PH12014500499A1 (en) 2014-04-14
SG11201400759RA (en) 2014-07-30
KR101584925B1 (ko) 2016-01-12
CA2846758C (en) 2017-09-12
CO6900144A2 (es) 2014-03-20
US8946427B2 (en) 2015-02-03
KR20140075716A (ko) 2014-06-19
EP2758396A1 (en) 2014-07-30

Similar Documents

Publication Publication Date Title
IL284539A (en) Heterocycloamines as PI3K inhibitors
ZA201306997B (en) Triazolopyridine compounds as pim kinase inhibitors
EP2716642A4 (en) imidazopyridine
IL231403A0 (en) Thiazolopyridine compounds as a10pde inhibitors
ZA201400374B (en) 4-piperidinyl compounds for use as tankyrase inhibitors
AP3529A (en) Hydroxymethylaryl-substituted pyrrolotriazines as alk1 inhibitors
IL228103A0 (en) Amino-quinolines as kinase inhibitors
ZA201303811B (en) Triazolopyridine compounds
IL235829A0 (en) Triazolo compounds as pde10 inhibitors
ZA201308697B (en) Hydroxymethylaryl-substituted pyprolotriazines as alk1 inhibitors
GB201120474D0 (en) Inhibitors